rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1997-3-20
|
pubmed:abstractText |
Octreotide scintigraphy has been reported to visualize chromaffine tumours. This study in patients with malignant phaeochromocytoma was designed to assess octreotide in comparison with standard m-iodobenzylguanidine (MIBG) scintigraphy and to study functional activity of somatostatin receptors. Finally, two cases of octreotide treatment are reported.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0300-0664
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
39-44
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9059556-3-Iodobenzylguanidine,
pubmed-meshheading:9059556-Adrenal Gland Neoplasms,
pubmed-meshheading:9059556-Adult,
pubmed-meshheading:9059556-Antineoplastic Agents,
pubmed-meshheading:9059556-Antineoplastic Agents, Hormonal,
pubmed-meshheading:9059556-Epinephrine,
pubmed-meshheading:9059556-Female,
pubmed-meshheading:9059556-Humans,
pubmed-meshheading:9059556-Indium Radioisotopes,
pubmed-meshheading:9059556-Iodine Radioisotopes,
pubmed-meshheading:9059556-Iodobenzenes,
pubmed-meshheading:9059556-Male,
pubmed-meshheading:9059556-Middle Aged,
pubmed-meshheading:9059556-Norepinephrine,
pubmed-meshheading:9059556-Octreotide,
pubmed-meshheading:9059556-Pheochromocytoma,
pubmed-meshheading:9059556-Prospective Studies,
pubmed-meshheading:9059556-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:9059556-Tomography, X-Ray Computed
|
pubmed:year |
1997
|
pubmed:articleTitle |
Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma.
|
pubmed:affiliation |
Department of Endocrinology and Metabolism, University of Magdeburg, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|